Abstract
Novel Process for the preparation of Lazertinib Mesylate The present invention relates to a novel process for the preparation of N-[5-[[4-[4-[(dimethylamino) methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2- morpholin-4-yl phenyl]acrylamide or a salt thereof, which is referred to as Lazertinib, represented by the following structural formulae
Formula-I
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
MSN Laboratories Private Limited, R&D Center, Hyderabad, India, Srinivasan Thirumalai Rajan, Sagyam Rajeshwar Reddy, Mohammad Rafee Shaik, Buvanagiri Ajay kumar, "Novel Process for the preparation of Lazertinib Mesylate", Technical Disclosure Commons, (August 26, 2026)
https://www.tdcommons.org/dpubs_series/11500